Prof. Antonino Lasco

Prof. Antonino Lasco, specialista in Endocrinologia, presso l'Università di Roma
Professore associato di Endocrinologia F.R. Università di Messina, già Direttore della Unità operativa e della scuola di specializzazione di Geriatria del Policlinico di Messina.
Responsabile del centro di Osteoporosi e malattie metaboliche dell'osso e del centro di Andrologia ed Endocrinologia del Dipartimento di Medicina Interna del Policlinico Universitario di Messina


Il Prof Antonino Lasco, già direttore della UOSD di Geriatria del Policlinico di Messina e della Scuola di Specializzazione in Geriatria dell’Università di Messina, è autore di numerose pubblicazioni su riviste scientifiche internazionali indicizzate con impact factor su temi di interesse in medicina interna, endocrinologia e geriatria.

As Time Goes by: Anxiety Negatively Affects the Perceived Quality of Life in Patients With Type 2 Diabetes of Long Duration.
Martino G, Catalano A, Bellone F, Russo GT, Vicario CM, Lasco A, Quattropani MC, Morabito N.
Front Psychol. 2019 Jul 31;10:1779. doi: 10.3389/fpsyg.2019.01779. eCollection 2019.

Correction: In thyroxine-replaced hypothyroid postmenopausal women under simultaneous calcium supplementation, switch to oral liquid or softgel capsule L-thyroxine ensures lower serum TSH levels and favorable effects on blood pressure, total cholesterolemia and glycemia.
Morini E, Catalano A, Lasco A, Morabito N, Benvenga S.
Endocrine. 2019 Sep;65(3):580-581. doi: 10.1007/s12020-019-01979-w.
PMID: 31254162


Trabecular bone score and quantitative ultrasound measurements in the assessment of bone health in breast cancer survivors assuming aromatase inhibitors.
Catalano A, Gaudio A, Agostino RM, Morabito N, Bellone F, Lasco A.
J Endocrinol Invest. 2019 Nov;42(11):1337-1343. doi: 10.1007/s40618-019-01063-0. Epub 2019 May 24.
PMID: 31127591

In thyroxine-replaced hypothyroid postmenopausal women under simultaneous calcium supplementation, switch to oral liquid or softgel capsule L-thyroxine ensures lower serum TSH levels and favorable effects on blood pressure, total cholesterolemia and glycemia.
Morini E, Catalano A, Lasco A, Morabito N, Benvenga S.
Endocrine. 2019 Sep;65(3):569-579. doi: 10.1007/s12020-019-01908-x. Epub 2019 Mar 27.

L-thyroxine malabsorption due to calcium carbonate impairs blood pressure, total cholesterolemia, and fasting glycemia.
Morini E, Catalano A, Lasco A, Morabito N, Benvenga S.
Endocrine. 2019 May;64(2):284-292. doi: 10.1007/s12020-018-1798-7. Epub 2018 Oct 27.

Neuropsychological Assessment in Elderly Men with Benign Prostatic Hyperplasia Treated with Dutasteride.
Catalano A, Martino G, Bellone F, Papalia M, Lasco C, Basile G, Sardella A, Nicocia G, Morabito N, Lasco A.
Clin Drug Investig. 2019 Jan;39(1):97-102. doi: 10.1007/s40261-018-0720-7.

Pulsed electromagnetic fields modulate bone metabolism via RANKL/OPG and Wnt/β-catenin pathways in women with postmenopausal osteoporosis: A pilot study.
Catalano A, Loddo S, Bellone F, Pecora C, Lasco A, Morabito N.
Bone. 2018 Nov;116:42-46. doi: 10.1016/j.bone.2018.07.010. Epub 2018 Jul 17.

Pathogenesis of Thalassemia Major-associated Osteoporosis: A Review with Insights from Clinical Experience.
Gaudio A, Morabito N, Catalano A, Rapisarda R, Xourafa A, Lasco A.
J Clin Res Pediatr Endocrinol. 2019 May 28;11(2):110-117. doi: 10.4274/jcrpe.galenos.2018.2018.0074.

Frailty modifications and prognostic impact in older patients admitted in acute care.
Basile G, Catalano A, Mandraffino G, Maltese G, Alibrandi A, Ciancio G, Brischetto D, Morabito N, Lasco A, Cesari M.
Aging Clin Exp Res. 2019 Jan;31(1):151-155. doi: 10.1007/s40520-018-0989-7. Epub 2018 Jun 26.

Anxiety levels predict fracture risk in postmenopausal women assessed for osteoporosis.
Catalano A, Martino G, Bellone F, Gaudio A, Lasco C, Langher V, Lasco A, Morabito N.
Menopause. 2018 Oct;25(10):1110-1115. doi: 10.1097/GME.0000000000001123.

Vitamin D Status and the Relationship with Bone Fragility Fractures in HIV-Infected Patients: A Case Control Study.
Atteritano M, Mirarchi L, Venanzi-Rullo E, Santoro D, Iaria C, Catalano A, Lasco A, Arcoraci V, Lo Gullo A, Bitto A, Squadrito F, Cascio A.
Int J Mol Sci. 2018 Jan 2;19(1):119. doi: 10.3390/ijms19010119.

Pain in Osteoporosis: From Pathophysiology to Therapeutic Approach.
Catalano A, Martino G, Morabito N, Scarcella C, Gaudio A, Basile G, Lasco A.
Drugs Aging. 2017 Oct;34(10):755-765. doi: 10.1007/s40266-017-0492-4.
Quantitative ultrasound and DXA measurements in aromatase inhibitor-treated breast cancer women receiving denosumab.
Catalano A, Gaudio A, Morabito N, Basile G, Agostino RM, Xourafa A, Atteritano M, Morini E, Natale G, Lasco A.
J Endocrinol Invest. 2017 Aug;40(8):851-857. doi: 10.1007/s40618-016-0606-6. Epub 2017 Mar 22.

Wnt antagonist sclerostin and Dickkopf-1 in gestational diabetes.
Catalano A, Pintaudi B, Morabito N, Giunta L, Loddo S, Corrado F, D'Anna R, Lasco A, Di Benedetto A.
Diabetes Metab. 2017 Sep;43(4):375-377. doi: 10.1016/j.diabet.2016.09.009. Epub 2016 Oct 27.

Skin Involvement and Pulmonary Hypertension Are Associated with Vitamin D Insufficiency in Scleroderma.
Atteritano M, Santoro D, Corallo G, Visalli E, Buemi M, Catalano A, Lasco A, Bitto A, Squadrito F.
Int J Mol Sci. 2016 Dec 14;17(12):2103. doi: 10.3390/ijms17122103.

Relationship between blood pressure and frailty in older hypertensive outpatients.
Basile G, Catalano A, Mandraffino G, Maltese G, Alibrandi A, Ciancio G, Lasco A, Cesari M.
Aging Clin Exp Res. 2017 Oct;29(5):1049-1053. doi: 10.1007/s40520-016-0684-5. Epub 2016 Nov 21.

Effects of teriparatide on bone mineral density and quality of life in Duchenne muscular dystrophy related osteoporosis: a case report.
Catalano A, Vita GL, Russo M, Vita G, Lasco A, Morabito N, Messina S.
Osteoporos Int. 2016 Dec;27(12):3655-3659. doi: 10.1007/s00198-016-3761-x. Epub 2016 Sep 2.

Bone health assessment by quantitative ultrasound and dual-energy x-ray absorptiometry in postmenopausal women with breast cancer receiving aromatase inhibitors.
Catalano A, Morabito N, Agostino RM, Basile G, Gaudio A, Atteritano M, Natale G, Xourafa A, Morini E, Adamo V, Lasco A.
Menopause. 2017 Jan;24(1):85-91. doi: 10.1097/GME.0000000000000722.

Does Vitamin D3 Have an Impact on Clinical and Biochemical Parameters Related to Third Molar Surgery.
Oteri G, Cicciù M, Peditto M, Catalano A, Loddo S, Pisano M, Lasco A.
J Craniofac Surg. 2016 Mar;27(2):469-76. doi: 10.1097/SCS.0000000000002389.

Inflammaging and Anti-Inflammaging: The Role of Cytokines in Extreme Longevity.
Minciullo PL, Catalano A, Mandraffino G, Casciaro M, Crucitti A, Maltese G, Morabito N, Lasco A, Gangemi S, Basile G.
Arch Immunol Ther Exp (Warsz). 2016 Apr;64(2):111-26. doi: 10.1007/s00005-015-0377-3. Epub 2015 Dec 12.

Denosumab Inhibition of RANKL and Insulin Resistance in Postmenopausal Women with Osteoporosis.
Lasco A, Morabito N, Basile G, Atteritano M, Gaudio A, Giorgianni GM, Morini E, Faraci B, Bellone F, Catalano A.
Calcif Tissue Int. 2016 Feb;98(2):123-8. doi: 10.1007/s00223-015-0075-5. Epub 2015 Oct 24.

Effects of strontium ranelate on markers of cardiovascular risk in postmenopausal osteoporotic women.
Atteritano M, Catalano A, Santoro D, Lasco A, Benvenga S.
Endocrine. 2016 Jul;53(1):305-12. doi: 10.1007/s12020-015-0721-8. Epub 2015 Aug 25.

Effects of strontium ranelate on bone mass and bone turnover in women with thalassemia major-related osteoporosis.
Morabito N, Catalano A, Gaudio A, Morini E, Bruno LM, Basile G, Tsiantouli E, Bellone F, Agostino RM, Piraino B, La Rosa MA, Salpietro C, Lasco A.
J Bone Miner Metab. 2016 Sep;34(5):540-6. doi: 10.1007/s00774-015-0689-8. Epub 2015 Jul 24.

Cognitive Impairment and Slow Gait Speed in Elderly Outpatients with Arterial Hypertension: The Effect of Blood Pressure Values.
Basile G, Catalano A, Mandraffino G, Crucitti A, Ciancio G, Morabito N, Lasco A.
J Am Geriatr Soc. 2015 Jun;63(6):1260-1. doi: 10.1111/jgs.13495.


Vitamin D and bone mineral density changes in postmenopausal women treated with strontium ranelate.
Catalano A, Morabito N, Di Stefano A, Morini E, Basile G, Faraci B, Loddo S, Ientile R, Lasco A.
J Endocrinol Invest. 2015 Aug;38(8):859-63. doi: 10.1007/s40618-015-0299-2. Epub 2015 May 8.

Calcifediol improves lipid profile in osteopenicatorvastatin-treated postmenopausal women.
Catalano A, Morabito N, Basile G, Cucinotta D, Lasco A.
Eur J Clin Invest. 2015 Feb;45(2):144-9. doi: 10.1111/eci.12390. Epub 2015 Jan 12.


Gender differences in sclerostin and clinical characteristics in type 1 diabetes mellitus.
Catalano A, Pintaudi B, Morabito N, Di Vieste G, Giunta L, Bruno ML, Cucinotta D, Lasco A, Di Benedetto A.
Eur J Endocrinol. 2014 Sep;171(3):293-300. doi: 10.1530/EJE-14-0106. Epub 2014 Jun 2.

Subclinical hypercortisol-assessment of bone fragility: experience of single osteoporosis center in Sicily.
Lasco A, Catalano A, Pilato A, Basile G, Mallamace A, Atteritano M.
Eur Rev Med Pharmacol Sci. 2014;18(3):352-8.

Fracture risk assessment in postmenopausal women referred to an Italian center for osteoporosis: a single day experience in Messina.
Catalano A, Morabito N, Basile G, Fusco S, Castagna G, Reitano F, Albanese RC, Lasco A.
Clin Cases Miner Bone Metab. 2013 Sep;10(3):191-4.

Estimating glomerular filtration rate in centenarians: comparison of the chronic kidney disease epidemiology collaboration (CKD-EPI) and modification of diet in renal disease (MDRD) study equations.
Basile G, Crucitti A, Fusco S, Cucinotta MD, Maltese G, Catalano A, Lasco A.
Int Urol Nephrol. 2014 Feb;46(2):481-2. doi: 10.1007/s11255-013-0518-8. Epub 2013 Aug 10.

Are physicians ready to prevent osteoporotic fractures in hemodialysis patients?
Lasco A, Catalano A, Morabito N.
Int J Endocrinol Metab. 2012 Fall;10(4):634-5. doi: 10.5812/ijem.6239. Epub 2012 Sep 30.

Zoledronic acid acutely increases sclerostin serum levels in women with postmenopausal osteoporosis.
Catalano A, Morabito N, Basile G, Brancatelli S, Cucinotta D, Lasco A.
J Clin Endocrinol Metab. 2013 May;98(5):1911-5. doi: 10.1210/jc.2012-4039. Epub 2013 Apr 17.

Impact of diabetes on cognitive impairment and disability in elderly hospitalized patients with heart failure.
Basile G, Crucitti A, Cucinotta MD, Figliomeni P, Lacquaniti A, Catalano A, Morabito N, Buemi M, Lasco A.
Geriatr Gerontol Int. 2013 Oct;13(4):1035-42. doi: 10.1111/ggi.12051. Epub 2013 Mar 19.

Hypocalcemia: a sometimes overlooked cause of heart failure in the elderly.
Catalano A, Basile G, Lasco A.
Aging Clin Exp Res. 2012 Aug;24(4):400-3. doi: 10.1007/BF03325272.

Phalangeal quantitative ultrasound and metabolic control in pre-menopausal women with type 1 diabetes mellitus.
Catalano A, Morabito N, Di Vieste G, Pintaudi B, Cucinotta D, Lasco A, Di Benedetto A.
J Endocrinol Invest. 2013 May;36(5):347-251. doi: 10.3275/8646. Epub 2012 Oct 1.

Improvement of primary dysmenorrhea caused by a single oral dose of vitamin D: results of a randomized, double-blind, placebo-controlled study.
Lasco A, Catalano A, Benvenga S.
Arch Intern Med. 2012 Feb 27;172(4):366-7. doi: 10.1001/archinternmed.2011.715.

Vitamin D reduces musculoskeletal pain after infusion of zoledronic acid for postmenopausal osteoporosis.
Catalano A, Morabito N, Atteritano M, Basile G, Cucinotta D, Lasco A.
Calcif Tissue Int. 2012 Apr;90(4):279-85. doi: 10.1007/s00223-012-9577-6. Epub 2012 Feb 16.

Electrocardiographic changes in centenarians: a study on 42 subjects and comparison with the literature.
Basile G, Cucinotta MD, Figliomeni P, Lo Balbo C, Maltese G, Lasco A.
Gerontology. 2012;58(3):216-20. doi: 10.1159/000330801. Epub 2011 Sep 7.

Healthy centenarians show high levels of circulating interleukin-22 (IL-22).
Basile G, Paffumi I, D'Angelo AG, Figliomeni P, Cucinotta MD, Pace E, Ferraro M, Saitta S, Lasco A, Gangemi S.
Arch Gerontol Geriatr. 2012 May-Jun;54(3):459-61. doi: 10.1016/j.archger.2011.05.004. Epub 2011 Jun 2.

Bone mineral density, quantitative ultrasound parameters and bone metabolism in postmenopausal women with depression.
Atteritano M, Lasco A, Mazzaferro S, Macrì I, Catalano A, Santangelo A, Bagnato G, Bagnato G, Frisina N.
Intern Emerg Med. 2013 Sep;8(6):485-91. doi: 10.1007/s11739-011-0628-1. Epub 2011 May 17.


Non smoking for successful aging: therapeutic perspectives.
Nicita-Mauro V, Maltese G, Nicita-Mauro C, Lasco A, Basile G.
Curr Pharm Des. 2010;16(7):775-82. doi: 10.2174/138161210790883552.

Adrenal effects of teriparatide in the treatment of severe postmenopausal osteoporosis.
Lasco A, Catalano A, Morabito N, Gaudio A, Basile G, Trifiletti A, Atteritano M.
Osteoporos Int. 2011 Jan;22(1):299-303. doi: 10.1007/s00198-010-1222-5. Epub 2010 Mar 23.

Haemostatic effects of phytoestrogen genistein in postmenopausal women.
Trifiletti A, Gaudio A, Lasco A, Atteritano M, Scamardi R, Pizzoleo MA, Morabito N, Frisina N.
Thromb Res. 2008;123(2):231-5. doi: 10.1016/j.thromres.2008.02.009. Epub 2008 Apr 14.

Bisphosphonates in the treatment of thalassemia-associated osteoporosis.
Gaudio A, Morabito N, Xourafa A, Macrì I, Meo A, Morgante S, Trifiletti A, Lasco A, Frisina N.
J Endocrinol Invest. 2008 Feb;31(2):181-4. doi: 10.1007/BF03345587.

The "lively" cytokines network in beta-Thalassemia Major-related osteoporosis.
Morabito N, Russo GT, Gaudio A, Lasco A, Catalano A, Morini E, Franchina F, Maisano D, La Rosa M, Plota M, Crifò A, Meo A, Frisina N.
Bone. 2007 Jun;40(6):1588-94. doi: 10.1016/j.bone.2007.02.020. Epub 2007 Mar 1.

Effect of long-term treatment with raloxifene on mammary density in postmenopausal women.
Lasco A, Gaudio A, Morini E, Morabito N, Nicita-Mauro C, Catalano A, Denuzzo G, Sansotta C, Xourafa A, Macrì I, Frisina N.
Menopause. 2006 Sep-Oct;13(5):787-92. doi: 10.1097/01.gme.0000233493.20712.ad.

Disappearance of a virilizing adrenal tumor following therapy with cyproterone acetate.
Lasco A, Morini E, Maglitto D, Campennì A, Benvenga S.
Endocr Relat Cancer. 2005 Dec;12(4):939-44. doi: 10.1677/erc.1.01065.

Hepatic osteodystrophy: does the osteoprotegerin/receptor activator of nuclear factor-kB ligand system play a role?
Gaudio A, Lasco A, Morabito N, Atteritano M, Vergara C, Catalano A, Fries W, Trifiletti A, Frisina N.
J Endocrinol Invest. 2005 Sep;28(8):677-82. doi: 10.1007/BF03347549.

Hemostatic effects of diets containing olive or soy oil in hypertensive patients.
Trifiletti A, Scamardi R, Gaudio A, Lasco A, Frisina N.
J Thromb Haemost. 2005 Jan;3(1):179-80. doi: 10.1111/j.1538-7836.2004.01095.x.

Neridronate prevents bone loss in patients receiving androgen deprivation therapy for prostate cancer.
Morabito N, Gaudio A, Lasco A, Catalano A, Atteritano M, Trifiletti A, Anastasi G, Melloni D, Frisina N.
J Bone Miner Res. 2004 Nov;19(11):1766-70. doi: 10.1359/JBMR.040813. Epub 2004 Aug 23.

Osteoprotegerin and RANKL in the pathogenesis of thalassemia-induced osteoporosis: new pieces of the puzzle.
Morabito N, Gaudio A, Lasco A, Atteritano M, Pizzoleo MA, Cincotta M, La Rosa M, Guarino R, Meo A, Frisina N.
J Bone Miner Res. 2004 May;19(5):722-7. doi: 10.1359/JBMR.040113. Epub 2004 Jan 12.

Effects of a long-term treatment with raloxifene on insulin sensitivity in postmenopausal women.
Lasco A, Gaudio A, Morabito N, Previti M, Mileto A, Frisina N, Cucinotta D.
Diabetologia. 2004 Mar;47(3):571-574. doi: 10.1007/s00125-004-1328-4. Epub 2004 Feb 5.

Long-term hemostatic effects of cholesterol-lowering therapy with atorvastatin.
Trifiletti A, Lasco A, Scamardi R, Pizzoleo MA, Gaudio A, La Rocca R, Morini E, Frisina N.
Pathophysiol Haemost Thromb. 2003 Mar-Apr;33(2):84-7. doi: 10.1159/000073851.

Three-year effectiveness of intravenous pamidronate versus pamidronate plus slow-release sodium fluoride for postmenopausal osteoporosis.
Morabito N, Gaudio A, Lasco A, Vergara C, Tallarida F, Crisafulli G, Trifiletti A, Cincotta M, Pizzoleo MA, Frisina N.
Osteoporos Int. 2003 Jul;14(6):500-6. doi: 10.1007/s00198-003-1397-0. Epub 2003 May 15.

Raloxifene and pituitary secretion in post-menopausal women.
Lasco A, Cannavò S, Gaudio A, Morabito N, Trifiletti A, Di Cesare E, Basile G, Nicita-Mauro V, Frisina N.
J Endocrinol Invest. 2002;25(10 Suppl):95-6.

Hemostasis and fibrinolysis factors in first-degree relatives of patients with Type 2 diabetes without hypertension.
Trifiletti A, Lasco A, Scamardi R, Cincotta M, Gaudio A, Barbera N, Frisina N.
Pathophysiol Haemost Thromb. 2002 May-Jun;32(3):127-30. doi: 10.1159/000065214.

Effects of long-lasting raloxifene treatment on serum prolactin and gonadotropin levels in postmenopausal women.
Lasco A, Cannavò S, Gaudio A, Morabito N, Basile G, Nicita-Mauro V, Frisina N.
Eur J Endocrinol. 2002 Oct;147(4):461-5. doi: 10.1530/eje.0.1470461.

Effects of genistein and hormone-replacement therapy on bone loss in early postmenopausal women: a randomized double-blind placebo-controlled study.
Morabito N, Crisafulli A, Vergara C, Gaudio A, Lasco A, Frisina N, D'Anna R, Corrado F, Pizzoleo MA, Cincotta M, Altavilla D, Ientile R, Squadrito F.
J Bone Miner Res. 2002 Oct;17(10):1904-12. doi: 10.1359/jbmr.2002.17.10.1904.

Bisphosphonates in the treatment of thalassemia-induced osteoporosis.
Morabito N, Lasco A, Gaudio A, Crisafulli A, Di Pietro C, Meo A, Frisina N.
Osteoporos Int. 2002 Aug;13(8):644-9. doi: 10.1007/s001980200087.

Osteoporosis and beta-thalassemia major: role of the IGF-I/IGFBP-III axis.
Lasco A, Morabito N, Gaudio A, Crisafulli A, Meo A, Denuzzo G, Frisina N.
J Endocrinol Invest. 2002 Apr;25(4):338-44. doi: 10.1007/BF03344015.

Recombinant human erythropoietin (rHuEPO): more than just the correction of uremic anemia.
Buemi M, Aloisi C, Cavallaro E, Corica F, Floccari F, Grasso G, Lasco A, Pettinato G, Ruello A, Sturiale A, Frisina N.
J Nephrol. 2002 Mar-Apr;15(2):97-103.

Metabolic effects of dehydroepiandrosterone replacement therapy in postmenopausal women.
Lasco A, Frisina N, Morabito N, Gaudio A, Morini E, Trifiletti A, Basile G, Nicita-Mauro V, Cucinotta D.
Eur J Endocrinol. 2001 Oct;145(4):457-61. doi: 10.1530/eje.0.1450457.

Randomized, double-blind, placebo-controlled study on effects of raloxifene and hormone replacement therapy on plasma no concentrations, endothelin-1 levels, and endothelium-dependent vasodilation in postmenopausal women.
Saitta A, Altavilla D, Cucinotta D, Morabito N, Frisina N, Corrado F, D'Anna R, Lasco A, Squadrito G, Gaudio A, Cancellieri F, Arcoraci V, Squadrito F.
Arterioscler Thromb Vasc Biol. 2001 Sep;21(9):1512-9. doi: 10.1161/hq0901.095565.

Effects of hormonal replacement therapy on bone metabolism in young adults with beta-thalassemia major.
Lasco A, Morabito N, Gaudio A, Buemi M, Wasniewska M, Frisina N.
Osteoporos Int. 2001;12(7):570-5. doi: 10.1007/s001980170079.
PMID: 11527055

Serum anti-p53 autoantibodies in patients with type 1 diabetes.
Di Cesare E, Previti M, Lombardo F, Di Benedetto A, Mazzù N, Romano G, De Luca F, Lasco A, Cucinotta D.
Ann Clin Lab Sci. 2001 Jul;31(3):253-8.

Correlation between family history of hypertension and haemostatic disorders.
Trifiletti A, Scamardi R, Cincotta M, Sottilotta G, Gaudio A, Romano C, Sottile L, Lasco A.
Minerva Med. 2001 Feb;92(1):19-21.

Long-term transdermal estrogen therapy improves lipid profile but not insulin resistance in healthy postmenopausal women.
Lasco A, Alvaro S, Frisina N, Di Benedetto A, Denuzzo G, Cucinotta D.
Diabetes Care. 2000 Mar;23(3):422-4. doi: 10.2337/diacare.23.3.422.
PMID: 10868880 Clinical Trial. No abstract available.

Effects of medium-term antihypertensive therapy on haemostatic parameters in patients with essential hypertension.
Trifiletti A, Barbera N, Scamardi R, Bagnato L, Pizzoleo MA, Nevoso A, Lasco A, Pedullà M, Frisina N.
Haemostasis. 1997 Jan-Feb;27(1):35-8. doi: 10.1159/000217431.

No changes of peripheral insulin resistance in polycystic ovary syndrome after long-term reduction of endogenous androgens with leuprolide.
Lasco A, Cucinotta D, Gigante A, Denuzzo G, Pedulla M, Trifiletti A, Frisina N.
Eur J Endocrinol. 1995 Dec;133(6):718-22. doi: 10.1530/eje.0.1330718.

Haemostatic variables in arterial hypertension.
Trifiletti A, Barbera N, Pizzoleo MA, Lasco A, Lucifora S, Leone G, Soraci S, Pedullà M, Frisina N.
Haemostasis. 1995 Sep-Oct;25(5):237-40. doi: 10.1159/000217166.

Sleep structure in essential hypertensive patients: differences between dippers and non-dippers.
Pedullà M, Silvestri R, Lasco A, Mento G, Lanuzza B, Sofia L, Frisina N.
Blood Press. 1995 Jul;4(4):232-7. doi: 10.3109/08037059509077600.

Premixed insulin at ratio 3/7 and regular + isophane insulins at mixing ratios from 2/8 to 4/6 achieve the same metabolic control.
Cucinotta D, Mannino D, Lasco A, Di Cesare E, Musolino C, Alessi R.
Diabete Metab. 1991 Jan-Feb;17(1):49-54.

Wake and sleep cardiovascular reflex tests and GH profiles in diabetic patients.
Silvestri R, Lasco A, Marabello L, Puglisi RM, Casella C, Cucinotta D, Manganaro O, Frisina N, Di Perri R.
Acta Diabetol Lat. 1989 Jul-Sep;26(3):237-44. doi: 10.1007/BF02581390.

Wakefulness and sleep autonomic dysfunction in diabetics.
Silvestri R, Marabello L, Lasco A, Mento G, Raffaele M, Leuzzi R, Lombardo N, Di Perri R.
Funct Neurol. 1989 Apr-Jun;4(2):189-91.

[Determination of serum fructosamine as a parameter of metabolic control in type 2 diabetes mellitus].
Cucinotta D, Lasco A, Di Cesare E, Perdichizzi G, De Leo A, Squadrito G.
Ann Ital Med Int. 1988 Apr-Jun;3(2):132-6.

Human alpha atrial natriuretic peptide inhibits angiotensin stimulated aldosterone biosynthesis in bovine adrenal glands.
Frisina N, Buemi M, Lasco A, Macri I, Squadrito F.
Horm Metab Res. 1987 Jul;19(7):309-11. doi: 10.1055/s-2007-1011807.

[The hypothalamo-hypophyseal system: the role of calcium ions].
Lasco A, Barbera N, Ciraolo O, Nicita-Mauro V.
Boll Soc Ital Biol Sper. 1983 May 30;59(5):655-61.

[The lipocorticotropic system and prolactin secretion].
Frisina N, Lasco A, Buemi M, Costa G.
Ann Endocrinol (Paris). 1983;44(4):243-6.

[The vasoactive effects of captopril (SQ 14225). Preliminary research].
Frisina N, Buemi M, Vitulo F, Lasco A, Ciraolo O, Nicita-Mauro V, Bonanno N, Squadrito G.
Boll Soc Ital Biol Sper. 1981 Feb 15;57(3):290-6.


[Effect of nifedipine on experimental myocardial infarct induced by isoproterenol].
Nicita-Mauro V, Barbera N, Ciraolo O, Carrozza G, Nicotina PA, Grosso M, Lasco A, Squadrito G.
Boll Soc Ital Cardiol. 1981;26(11):1645-54.

[The dopaminergic system and aldosterone secretion. II. Effect of L-dopa and dexamethasone on aldosterone biosynthesis].
Frisina N, Buemi M, Lasco A, Vitulo F, Ciraolo O, Costa G, Nicita-Mauro V.
Boll Soc Ital Biol Sper. 1980 Nov 30;56(22):2290-6.

[The dopaminergic system and aldosterone secretion. I. Suppressive effects of L-dopa on secondary hyperaldosteronism].
Frisina N, Buemi M, Ciraolo O, Naso G, Lasco A, Costa G.
Boll Soc Ital Biol Sper. 1980 Nov 30;56(22):2284-8.

[Saralasin in subjects with low renin arterial hypertension].
Frisina N, Buemi M, Lasco A, Macrí I, Ciraolo O, Nicita Mauro V, Costa G.
Boll Soc Ital Biol Sper. 1980 Jul 15;56(13):1367-73.


[Production of corticosterone in vitro: role of PGE2].
Frisina N, De Pasquale R, Lasco A, Buemi M, Macrì I, Costa G.
Boll Soc Ital Biol Sper. 1980 Jul 15;56(13):1380-4.
PMID: 6255972 Italian.

[Aldosterone production in vitro by angiotensin II: the role of Ca++].
Frisina N, Nicita Mauro V, De Pasquale R, Lasco A, Buemi M, Ciraolo O, Costa G.
Boll Soc Ital Biol Sper. 1980 Jul 15;56(13):1374-9.

[Inhibitory effects of indomethacin on prolactin liberation induced with peptides with opium-like activity].
Costa G, Frisina N, Forestieri AM, Lasco A, De Pasquale R, Squadrito G.
Boll Soc Ital Biol Sper. 1979 Dec 15;55(23):2425-30.

[Obesity and gonadotropins. The pulsatile pattern of LH in obese women].
Frisina N, Lasco A, Nicita-Mauro V, Buemi M, Barbera N, Squadrito G.
Minerva Med. 1979 May 12;70(23):1645-50.

[Obesity and gonadotropins. The synthetic gonadotropin releasing hormone test in obese women].
Frisina N, Lasco A, Nicita MV, Bellinghieri G, Mallamace A, Squadrito G.
Minerva Med. 1979 May 12;70(23):1641-4.

[Aldosterone and prolactin secretion. I. Effects of sulpiride on plasma aldosterone levels in normal subjects].
Frisina N, Costa G, Buemi M, Lasco A.
Boll Soc Ital Biol Sper. 1978 Dec 15;54(23):2473-6.

[Effect of a calcium antagonist, nifedipine, on the cold pressor test in normal subjects].
Nicita-Mauro V, Barbera N, Buemi M, Lasco A, Frisina N.
Boll Soc Ital Biol Sper. 1978 Oct 30;54(20):1998-2002.

[Prostaglandins and renin secretion: effect of indomethacin].
Frisina N, Buemi M, Nicita-Mauro V, Bellinghieri G, Lasco A, Ceruso D.
Boll Soc Ital Biol Sper. 1978 Oct 15;54(19):1841-6.

[Changes in the pulsatile pattern of LH caused by L-DOPA administration in normal women].
Frisina N, Lasco A, Buemi M, Trovato A, Nicita-Mauro V, Costa G.
Boll Soc Ital Biol Sper. 1978 Sep 30;54(18):1665-9.

[Regulation of the renin-angiotensin-aldosterone system. Role of the prostaglandins].
Frisina N, Buemi M, Lasco A, Bellinghieri G, Lo Schiavo F, Ceruso D.
Minerva Med. 1978 Sep 15;69(42):2855-60.

[Influence of verapamil on blood sugar and insulin levels after administration of glucose. Experimental and clinical study].
Nicita-Mauro V, Frisina N, Buemi M, Costa G, Lasco A, Ceruso D.
Boll Soc Ital Cardiol. 1978;23(2):380-8.

[Influence of verapamil on the cold pressor test in normal subjects].
Nicita-Mauro V, Barbera N, Lasco A, Mallamace A, Frisina N.
Boll Soc Ital Cardiol. 1978;23(2):374-9.
PMID: 754795 Italian. No abstract available.

[Influence of prostaglandins on the regulation of renin secretion. Experimental and clinical research].
Frisina N, Nicita-Mauro V, Buemi M, Costa G, Lasco A, Ceruso D.
Boll Soc Ital Cardiol. 1977;22(8):1397-403.